Ingalls & Snyder LLC’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20,376	Closed	-$3.74M	–	482
2021 Q2	$3.74M	Sell	20,376 -110	-0.5%	-$18.9K	0.17%	108
2021 Q1	$3.13M	Buy	20,486 +76	+0.4%	+$11.8K	0.15%	116
2020 Q4	$3.19M	Buy	+20,410	New	+$2.62M	0.16%	110
2020 Q3	–	Sell	-21,590	Closed	-$2.42M	–	434
2020 Q2	$2.42M	Sell	21,590 -225	-1%	-$23.9K	0.14%	114
2020 Q1	$1.96M	Buy	+21,815	New	+$2.14M	0.13%	125
2019 Q4	–	Sell	-26,348	Closed	-$2.58M	–	447
2019 Q3	$2.58M	Sell	26,348 -1,096	-4%	-$124K	0.13%	131
2019 Q2	$3.6M	Buy	27,444 +751	+3%	+$96.8K	0.17%	110
2019 Q1	$3.61M	Buy	26,693 +4,249	+19%	+$528K	0.17%	110
2018 Q4	$2.19M	Buy	22,444 +15,367	+217%	+$1.82M	0.12%	138
2018 Q3	$984K	Buy	7,077 +285	+4%	+$35.8K	0.04%	239
2018 Q2	$843K	Sell	6,792 -207	-3%	-$24.2K	0.04%	225
2018 Q1	$780K	Sell	6,999 -365	-5%	-$43.6K	0.04%	227
2017 Q4	$881K	Buy	+7,364	New	+$897K	0.04%	225
2017 Q2	–	Sell	-4,000	Closed	-$485K	–	415
2017 Q1	$485K	Hold	4,000	–	–	0.03%	259
2016 Q4	$489K	Hold	4,000	–	–	0.03%	256
2016 Q3	$490K	Hold	4,000	–	–	0.03%	254
2016 Q2	$467K	Hold	4,000	–	–	0.03%	263
2016 Q1	$556K	Hold	4,000	–	–	0.04%	219
2015 Q4	$763K	Hold	4,000	–	–	0.05%	191
2015 Q3	$625K	Hold	4,000	–	–	0.04%	204
2015 Q2	$723K	Hold	4,000	–	–	0.04%	201
2015 Q1	$693K	Hold	4,000	–	–	0.04%	211
2014 Q4	$740K	Hold	4,000	–	–	0.04%	205
2014 Q3	$663K	Hold	4,000	–	–	0.04%	209
2014 Q2	$625K	Hold	4,000	–	–	0.03%	225
2014 Q1	$608K	Hold	4,000	–	–	0.03%	220
2013 Q4	$531K	Hold	4,000	–	–	0.03%	226
2013 Q3	$464K	Hold	4,000	–	–	0.03%	234
2013 Q2	$368K	Buy	+4,000	New	+$385K	0.02%	257

Other funds holding ALXN